Skip to main content
. 2015 Apr 29;6(19):17379–17390. doi: 10.18632/oncotarget.3954

Figure 3. Analysis of TMEM100 expression in ANLTs, well differentiated hepatocellular carcinoma and poorly differentiated hepatocellular carcinoma by IHC.

Figure 3

A.&D. The expression of TMEM100 was strong positive in ANLTs (A:100×, D:400×). B.&E. The expression of TMEM100 was moderate positive in well differentiated hepatocellular carcinoma (B:100×, E:400×). C.&F. The expression of TMEM100 was week positive or negative in poorly differentiated hepatocellular carcinoma (C:100×, F:400×).